UPM Pharmaceuticals has purchased and qualified a Q20 Auto MDSC (Differential Scanning Calorimeter) and a Q50 TGA (Thermogravimetric Analyzer) by TA Instruments. The equipment enhances the company’s pre-formulation studies, and also supports analytical testing of challenging formulations, including poorly soluble compounds.
UPM’s president, Jim Gregory, said, “UPM sees these new pieces of analytical equipment combined with our already highly qualified and experienced analytical team as a powerful combination for our clients who are trying to make the best and most cost effective decisions about investment of precious research funds. And further is looking for a partner that can perform the latest and best analysis with the most reliable equipment available in the pre-formulation stage of development.”
UPM Pharmaceuticals provides customized formulation development, manufacturing, and analytical services to pharmaceutical, biotechnology, academic, and veterinary clients.